|
XPOT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.781440E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.607800E-02 |
| Normal-vs-Stage2 |
3.223600E-01 |
| Normal-vs-Stage3 |
1.262030E-01 |
| Normal-vs-Stage4 |
1.995060E-03 |
| Stage1-vs-Stage2 |
7.944600E-01 |
| Stage1-vs-Stage3 |
9.206200E-01 |
| Stage1-vs-Stage4 |
3.243600E-02 |
| Stage2-vs-Stage3 |
8.802400E-01 |
| Stage2-vs-Stage4 |
5.256300E-02 |
| Stage3-vs-Stage4 |
4.252100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.098890E-03 |
| Normal-vs-AfricanAmerican |
6.715000E-01 |
| Normal-vs-Asian |
2.601000E-01 |
| Caucasian-vs-AfricanAmerican |
3.792400E-02 |
| Caucasian-vs-Asian |
3.104200E-01 |
| AfricanAmerican-vs-Asian |
2.322200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.249400E-04 |
| Normal-vs-Female |
1.005650E-01 |
| Male-vs-Female |
8.629800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.027800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.225700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.862960E-03 |
| Normal-vs-Age(81-100Yrs) |
5.626200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.425000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.339400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.170400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.247600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.778200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.559600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.336200E-01 |
| Normal-vs-Grade 2 |
2.724300E-02 |
| Normal-vs-Grade 3 |
9.988100E-02 |
| Normal-vs-Grade 4 |
6.378000E-04 |
| Grade 1-vs-Grade 2 |
7.240600E-01 |
| Grade 1-vs-Grade 3 |
8.408800E-01 |
| Grade 1-vs-Grade 4 |
4.916100E-02 |
| Grade 2-vs-Grade 3 |
7.581800E-01 |
| Grade 2-vs-Grade 4 |
1.652340E-02 |
| Grade 3-vs-Grade 4 |
1.280330E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.033500E-02 |
| Normal-vs-ccB subtype |
2.606600E-04 |
| ccA subtype-vs-ccB subtype |
1.417760E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.298300E-03 |
| Normal-vs-N1 |
3.242300E-02 |
| N0-vs-N1 |
9.262300E-02 |
|
|
